腹腔内脂肪面积正常的非酒精性脂肪性肝病的危险因素分析

黄志鹏; 蒋建家; 黄子成; 郭桂元; 周阿佩; 刘晓强

doi:10.3969/j.issn.1001-5256.2019.05.025

腹腔内脂肪面积正常的非酒精性脂肪性肝病的危险因素分析

DOI: 10.3969/j.issn.1001-5256.2019.05.025

1. 福建医科大学附属泉州第一医院消化内科
2. 福建医科大学附属泉州第一医院内分泌科

基金项目:

泉州市第一医院青年科研课题(2014-QN-03)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 1487
- HTML全文浏览量: 39
- PDF下载量: 309
- 被引次数: 0
出版历程
- 收稿日期: 2018-10-15
- 出版日期: 2019-05-20

Risk factors of nonalcoholic fatty liver disease with a normal visceral adipose tissue area

Department of Gastroenterology, Quanzhou First Hospital Affiliated to Fujian Medical University

Research funding:

摘要

摘要: 目的明确腹腔内脂肪面积（VAT）正常的非酒精性脂肪性肝病（NAFLD）的危险因素及其胰岛素抵抗（IR）状态。方法选取2017年6月-2018年5月福建医科大学附属泉州第一医院收集的45例VAT正常的NAFLD患者为观察组,另取同期27例VAT正常且非NAFLD者作为对照组。分别测定2组对象的VAT、腰围、空腹血糖（FBG）、空腹胰岛素（FINS）等指标,计算IR指数（HOMA-IR）,并分析IR与腰围等指标的相关性。正态分布的计量资料2组间比较采用独立样本t检验,非正态分布者采用Mann-Whitney U检验,计数资料2组间比较采用χ2检验。正态分布的计量资料相关性比较采用Pearson相关分析,非正态分布者采用Spearman相关分析。危险因素分析采用logistic回归分析（向前法）。结果 VAT正常的NAFLD组IR水平较对照组高,HOMA-IR2组间差异有统计学意义[2. 66（1. 59～4. 06） vs 1. 84（1. 25～2. 47）,Z=364. 000,P=0. 005]; IR与FBG、FINS、TG呈正相关,r值分别为0. 412、0...
- 非酒精性脂肪性肝病 /
- 腹内脂肪 /
- 危险因素
Abstract: Objective To investigate the risk factors and insulin resistance ( IR) of nonalcoholic fatty liver disease ( NAFLD) with a normal visceral adipose tissue ( VAT) area. Methods A total of 45 NAFLD persons with a normal VAT area who were admitted to Quanzhou First Hospital Affiliated to Fujian Medical University from June 2017 to May 2018 were enrolled as observation group, and 27 non-NAFLD patients with a normal VAT area were enrolled as control group. VAT area, waist circumference, fasting blood glucose ( FBG) , and fasting insulin ( FINS) were measured for both groups, homeostasis model assessment of insulin resistance ( HOMA-IR) was calculated, and the correlation of IR with the indices including waist circumference was analyzed. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between groups. Pearson correlation analysis and Spearman correlation analysis were used to investigate the correlation of normally and non-normally distributed continuous data. A forward logistic regression analysis was used to identify related risk factors. Results The NAFLD group had a significantly higher level of IR than the control group, and there was a significant difference in HOMA-IR between the two groups ( 2. 66 ( 1. 59-4. 06) vs 1. 84 ( 1. 25-2. 47) , Z = 364. 000, P = 0. 005) . IR was positively correlated with FBG ( r = 0. 412, P = 0. 005) , FINS ( r = 0. 789, P <0. 001) , and TG ( r = 0. 306, P = 0. 041) . IR was negatively correlated with HDL ( r =-9. 398, P = 0. 007) . The multivariate regression analysis showed that waist circumference was an independent risk factor for NAFLD with a normal VAT area ( regression coefficient = 0. 181, odds ratio = 1. 198, 95% confidence interval: 1. 099-1. 306, P < 0. 001) . Conclusion There is a certain degree of IR in NAFLD patients with a normal VAT, and waist circumference is an independent risk for NAFLD with a normal VAT.
- non-alcoholic fatty liver disease /
- intra-abdominal fat /
- risk factors

HTML全文

参考文献(20)

[1] ZELBER-SAGI S, RATZIU V, OREN R. Nutrition and physical activity in NAFLD:An overview of the epidemiological evidence[J]. World Gastroenterol, 2011, 17 (29) :3377-3389.

[2] FABBRINI E, SULLIVAN S, KLEIN S. Obesity and nonalcoholic fatty liver disease:Biochemical, metabolic, and clinical implications[J]. Hepatology, 2010, 51:679-689.

[3] MARGARITI E, DEUTSCH M, MANOLAKOPOULOS S, et al.Nonalcoholic fatty liver disease may develop in individuals with normal body mass index[J]. Ann Gastroenterol, 2012, 25 (1) :45-51.

[4] HUANG ZP, SU ZJ, JIANG JJ, et al. The analysis of the relationship between the extence of non-alcoholic fatty liver disease and metabolic syndrome’s components[J]. Clin Med China, 2013, 29 (11) :1158-1161. (in Chinese) 黄志鹏, 苏智军, 蒋建家, 等.非酒精性脂肪肝严重程度与代谢综合征组分的相关性分析[J].中国综合临床, 2013, 29 (11) :1158-1161.

[5] ZHAO ZG. Relationship between C-reactive protein and visceral fat obesity and their impacts on target organ damage[D]. Chongqing:The Third Military Medical University, 2009. (in Chinese) 赵志钢. C反应蛋白与内脏脂肪型肥胖及其相关靶器官损害的关系[D].重庆:第三军医大学, 2009.

[6] The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association.Guidelines for management of nonalcoholic fatty liver diseas[J]. J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[7] Department of Disease Control, Ministry of Health of the People’s Republic of China. Guide-lines for prevention and control of overweight and obesity in Chinese adults (Excerpt) [J]. Acta Nutrimenta Sinica, 2004, 26 (1) :1-4. (in Chinese) 中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防与控制指南 (节录) [J].营养学报, 2004, 26 (1) :1-4.

[8] CHUNG GE, KIM D, KWARK MS, et al. Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease[J]. Medicine, 2015, 94 (9) :1-8.

[9] KIM D, KIM WR. Nonobese fatty liver disease[J]. Clin Gastroenterol Hepatol, 2017, 15 (4) :474-485.

[10] GONZALEZ-CANTERO J, MARTIN-RODRIGUEZ JL, GONZALEZ-CANTERO A, et al. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese his-panic patients:A pilot study[J]. Lipids Health Dis, 2017, 16 (1) :129.

[11] BUGIANESI E, ZANNONI C, VANNI E, et al. Non-alcoholic fatty liver and insulin resistance:A cause-effect relationship?[J]. Dig Liver Dis, 2004, 36 (3) :165-173.

[12] BHAT G, BABA CS, PANDEY A, et al. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease[J]. World J Hepatol, 2012, 4 (7) :209-217.

[13] LI C, GUO P, OKEKUNLE AP, et al. Lean non-alcoholic fatty liver disease patients had compareable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver diseasepatients[J]. J Gastroenterol Hepatol, 2018.[Epub ahead of print]

[14] DAS K, DAS K, MUKHERJEE PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease[J]. Hepatology, 2010, 51:1593-1602.

[15] KUMAR R, MOHAN S. Non-alcoholic fatty liver disease in lean subjects:Characteristics and Implications[J]. J Clin Transl Hepatol, 2017, 5 (3) :216-223.

[16] BHAT G, BABA CS, PANDEY A, et al. Insulin resistance and metabolic syndrome in non-obese Indian patients with nonalcoholic fatty liver disease[J]. Trop Gastroenterol, 2013, 34 (1) :18-24.

[17] GONZALEZ-CANTERO J, MARTIN-RODRIGUEZ JL, GONZALEZ-CANTERO A, et al. Insulin resistance in lean and overweight non-diabetic Caucasian adults:Study of its relationship with liver triglyceride content, waist circumference and BMI[J]. PLo S One, 2018, 13 (2) :1-13.

[18] FRACANZANI AL, VALENTI L, BUGIANESI E, et al. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity[J]. J Hepatol, 2011, 54:1244-1249.

[19] SOOKOIAN S, PIROLA CJ. Systematic review with meta-analysis:Risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile betweenn lean and obese patients[J]. Aliment Pharmacol Ther, 2017, 46 (2) :85-95.

[20] LENG XJ, YAN XB. Efficiency of FibroTouch in evaluating liver fibrosis degree in nonalcoholic fatty liver disease patients with different levels of body mass index[J]. J Clin Hepatol, 2018, 34 (9) :1891-1895. (in Chinese) 冷雪君, 颜学兵. FibroTouch对不同BMI水平非酒精性脂肪性肝病患者肝纤维化程度的评估比较[J].临床肝胆病杂志, 2018, 34 (9) :1891-1895.

施引文献

资源附件(0)

访问统计